RESUMEN
OBJECTIVE: Many definitions used in medically assisted reproduction (MAR) vary in different settings, making it difficult to standardize and compare procedures in different countries and regions. With the expansion of infertility interventions worldwide, including lower resource settings, the importance and value of a common nomenclature is critical. The objective is to develop an internationally accepted and continually updated set of definitions, which would be utilized to standardize and harmonize international data collection, and to assist in monitoring the availability, efficacy, and safety of assisted reproductive technology (ART) being practiced worldwide. METHOD: Seventy-two clinicians, basic scientists, epidemiologists and social scientists gathered together at the World Health Organization headquarters in Geneva, Switzerland, in December 2008. Several months before, three working groups were established as responsible for terminology in three specific areas: clinical conditions and procedures, laboratory procedures, and outcome measures. Each group reviewed the existing International Committee for Monitoring Assisted Reproductive Technology glossary, made recommendations for revisions and introduced new terms to be considered for glossary expansion. RESULT(S): A consensus was reached on 87 terms, expanding the original glossary by 34 terms, which included definitions for numerous clinical and laboratory procedures. Special emphasis was placed in describing outcome measures, such as cumulative delivery rates and other markers of safety and efficacy in ART. CONCLUSION(S): Standardized terminology should assist in analysis of worldwide trends in MAR interventions and in the comparison of ART outcomes across countries and regions. This glossary will contribute to a more standardized communication among professionals responsible for ART practice, as well as those responsible for national, regional, and international registries.
Asunto(s)
Comités de Monitoreo de Datos de Ensayos Clínicos , Técnicas Reproductivas Asistidas/clasificación , Técnicas Reproductivas Asistidas/legislación & jurisprudencia , Terminología como Asunto , Organización Mundial de la Salud , Comités de Monitoreo de Datos de Ensayos Clínicos/legislación & jurisprudencia , Comités de Monitoreo de Datos de Ensayos Clínicos/organización & administración , Femenino , Humanos , Agencias Internacionales/legislación & jurisprudencia , Agencias Internacionales/organización & administración , Masculino , Embarazo , Organización Mundial de la Salud/organización & administraciónRESUMEN
A proteção dos participantes nas pesquisas que envolvem seres humanos é uma das atribuições fundamentais dos Comitês de Ética em Pesquisa (CEPs), estando regulamentada em âmbito nacional e internacional. Segundo esses documentos, cabe aos CEPs não só revisar todos os protocolos de pesquisa submetidos a ele, mas também monitorar a ocorrência dos eventos adversos (EA) encaminhados pelo pesquisador no transcorrer da pesquisa. Esse monitoramento deve ser ágil e crítico, orientando sua ação em observância à relação dano/benefício de cada estudo, com o objetivo de proteger os participantes de pesquisa. O Grupo de Pesquisa e Pós-Graduação do Hospital de Clínicas de Porto Alegre (HCPA) implantou, em 2001, o Programa de Monitoramento de Riscos e Eventos Adversos, que atualmente é desenvolvido pelo Laboratório de Pesquisa em Bioética e Ética na Ciência
Based on national and international regulations, one of the the Research Ethics Committees (REC) have the attribution to protect human beings involved in research. According to these documents, REC should not only review all the research protocols, but also monitor adverse events (AE) reported by the investigator. This monitoring activities must be agile and critical, guiding its actions by evaluation of risk/benefit associated to each study. The Grupo de Pesquisa e Pós-Graduação of the Hospital de Clínicas de Porto Alegre (HCPA) introduced, in 2001, the Program of Monitoring of Risks and Adverse Events, developed by the Laboratório de Pesquisa em Bioética e Ética na Ciência